Bellete Ambaw has filed 3 insider transactions across 1 company since October 2024.
Most recent transaction: a grant/award of 107508 shares of CG Oncology, Inc. ($CGON) on April 15, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| April 15, 2026 | CG Oncology, Inc. | $CGON | Bellete Ambaw | President and COO | A | Employee Stock Option (Right to Buy) | 107508 | $0.00 | 107,508.0000 | 80,666,179 | 9999.99% | 0.13% |
| April 15, 2025 | CG Oncology, Inc. | $CGON | Bellete Ambaw | President and COO | A | Employee Stock Option (Right to Buy) | 284816 | $0.00 | 284,816.0000 | 76,216,855 | 9999.99% | 0.37% |
| Oct. 4, 2024 | CG Oncology, Inc. | $CGON | Bellete Ambaw | President and COO | A | Stock Option (Right to Buy) | 175500 | $0.00 | 175,500.0000 | 0 | 9999.99% | 0.00% |